<SEC-DOCUMENT>0001193125-20-129862.txt : 20200501
<SEC-HEADER>0001193125-20-129862.hdr.sgml : 20200501
<ACCEPTANCE-DATETIME>20200501090556
ACCESSION NUMBER:		0001193125-20-129862
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20200501
DATE AS OF CHANGE:		20200501
EFFECTIVENESS DATE:		20200501

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MICROVISION, INC.
		CENTRAL INDEX KEY:			0000065770
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC COMPONENTS, NEC [3679]
		IRS NUMBER:				911600822
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34170
		FILM NUMBER:		20838596

	BUSINESS ADDRESS:	
		STREET 1:		6244 185TH AVENUE NE, SUITE 100
		CITY:			REDMOND
		STATE:			WA
		ZIP:			98052
		BUSINESS PHONE:		425-936-6847

	MAIL ADDRESS:	
		STREET 1:		6244 185TH AVENUE NE, SUITE 100
		CITY:			REDMOND
		STATE:			WA
		ZIP:			98052

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MICROVISION INC
		DATE OF NAME CHANGE:	19960724
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d915232ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a Party other than the Registrant&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant <FONT STYLE="white-space:nowrap">to&nbsp;&#167;240.14a-12</FONT>
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>MICROVISION, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table below per Exchange Act
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Rules&nbsp;14a-6(i)(1)&nbsp;and&nbsp;0-11.</FONT></FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Title of each class of securities to which transaction applies: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:9%;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Aggregate number of securities to which transaction applies: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:9%;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Per unit price or other underlying value of transaction computed pursuant to Exchange Act <FONT
STYLE="white-space:nowrap">Rule&nbsp;0-11&nbsp;(set</FONT> forth the amount on which the filing fee is calculated and state how it was determined): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:9%;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposed maximum aggregate value of transaction: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:9%;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Total fee paid: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:9%;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Check box if any part of the fee is offset as provided by Exchange Act
<FONT STYLE="white-space:nowrap">Rule&nbsp;0-11(a)(2)&nbsp;and</FONT> identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its
filing. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amount Previously Paid: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:9%;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Form, Schedule or Registration Statement No.: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:9%;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Filing Party: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:9%;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Date Filed: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:9%;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g915232g46j35.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;1, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear
Fellow MicroVision Shareholder, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I write to ask for your help in achieving our common goal to maximize the market value of MicroVision. When I assumed the
CEO role earlier this year we faced uncertainties on our 2020 business objectives and OEM partnerships. As a result, we changed course and committed ourselves to finding strategic alternatives for success, including the potential sale of the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We continue to work diligently to explore all options with several interested parties on potential licensing, sale or merger transactions. We
are making progress in our discussions with several parties with the help of our financial advisor, Craig-Hallum Capital Group LLC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have an important
task ahead of us: approval of a key shareholder proposal outlined in our Proxy Statement dated April&nbsp;3, 2020 relating to a reverse stock split. Your approval of Proposal 3 will enable MicroVision to maintain our listing on the Nasdaq Global
Market, provide you with liquidity for your investment and help facilitate a tender offer or exchange of shares in a sale or merger transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Your Vote &#147;FOR&#148; Proposal 3 Approving a Potential Reverse Stock Split </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>is Important to MicroVision&#146;s Future </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A reverse stock split has no inherent effect on the company&#146;s total&nbsp;market capitalization or your percentage ownership in the Company. Board
members, management and employees with vested or unvested stock or option awards will be impacted in the same way as other shareholders. Regardless, I want you to know that I, along with the management team, employees and Board of Directors will
continue to work hard to find ways to maximize the value of the Company and your shares. I encourage you to refer to the Proxy Statement for a discussion of benefits and risks, but I want to highlight some of the expected benefits of approving
Proposal 3: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Remain Listed on the Nasdaq Global Market and Maintain Liquidity:</B><B> </B>The Nasdaq Global Market provides
a market that attracts a wide group of investors.<B> </B>If the Company were delisted it could adversely affect the number of potential investors and liquidity of your shares. Listing on the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> (OTC) market or a regional stock exchange would likely make it harder to obtain a quote or sell your shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Facilitate Tender or Exchange of Shares in the Event of a Sale or Merger: </B>Listing on Nasdaq enhances our
ability to consider and possibly facilitate a tender offer or exchange of shares in the event a sale or merger, which are among the opportunities we are exploring to maximize shareholder value. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>A Reverse Stock Split Maintains Percentage Ownership and Applies Uniformly: </B>A reverse stock split will not
affect your percentage ownership in MicroVision or total value of your shares. Also, a reverse split is applied uniformly to ALL past and present employees with vested or unvested equity awards. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>MicroVision,&nbsp;Inc.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">6244&nbsp;185th&nbsp;Avenue&nbsp;NE<BR> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">Suite&nbsp;100</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">Redmond,&nbsp;WA&nbsp;98052,&nbsp;USA</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Tel&nbsp;&nbsp;&nbsp;&nbsp;(425)&nbsp;936-6847</FONT><BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Fax&nbsp;&nbsp;&nbsp;&nbsp;(425)&nbsp;867-9992</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">microvision.com</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors understands that some shareholders are reluctant to authorize a reverse stock split
but believes strongly and unanimously that the Company and shareholders will be served best by voting FOR Proposal 3. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Glass Lewis, a leading independent
proxy advisory firm, relied upon by hundreds of major institutional investment firms and mutual funds, agrees with the Board that a vote FOR a reverse stock split is in the best interest of the Company to reduce the number of shares of common stock
outstanding, attempt to proportionally raise the per share price of the Company&#146;s common stock and increase investor interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your vote is
important regardless of the number of shares you own. If you have already voted no on Proposal 3 I encourage you to change your vote. Approval requires a majority of shareholders to vote in favor of the proposal and not voting is the same as a vote
against the proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Company needs your support by voting FOR Proposal 3. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>How to Vote </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To vote or
if you have already voted and would like to change your vote or if you have any questions or need assistance voting your shares, please call the firm assisting us with the solicitation of proxies: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Saratoga Proxy Consulting LLC, at (212) <FONT STYLE="white-space:nowrap">257-1311</FONT> or (888)
<FONT STYLE="white-space:nowrap">368-0379.</FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your investments allowed our engineers to create valuable technology that is currently shipping in
a top tier OEM product. I believe our technology has timely arrived at an inflection point with the possibility of products aligning with several consumer vertical markets. Your vote FOR Proposal 3 is important to facilitate our efforts to maximize
value for our shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thank you for your continuing support, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g915232g73p79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sumit Sharma </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive
Officer </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain statements contained in this letter, including those relating to benefits of the approval of Proposal 3 of the Proxy Statement, effects
and benefits or a reverse stock split, potential success in realizing strategic options, discussion with third parties regarding licensing and other strategic options, potential sale or merger of the Company, stock liquidity, value of shares
following a reverse stock split, maximizing value of the Company and Shares of common stock. potential products and markets, and those containing words such as &#147;expect&#148; and &#147;believe,&#148; are forward-looking statements that involve
risks and uncertainties. Factors that could cause actual results to differ materially from those projected in our forward-looking statements include the risk that the company may not succeed in finding licensing or other strategic solutions,
including a potential sale of the company, with acceptable timing, benefits or costs, the company may be unable to evidence compliance with Nasdaq criteria within the period of time that was granted by the Nasdaq panel; the risk that our stock price
could decline following a reverse stock split; our ability to operate with limited cash or to raise additional capital when needed; market acceptance of our technologies and products; and for products incorporating our
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
technologies; the failure of our commercial partners to perform as expected under our agreements, including from the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> (coronavirus);
our ability to identify parties interested in paying any amounts or amounts we deem desirable for the purchase or license of intellectual property assets; our or our customers&#146; failure to perform under open purchase orders, our financial and
technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary
technologies; the ability to obtain additional contract awards and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products;
dependence on third parties to develop, manufacture, sell and market our products; potential product liability claims; our ability to maintain our listing on the Nasdaq Stock Market, and other risk factors identified from time to time in the
company&#146;s SEC reports, including the company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> filed with the SEC. These factors are not intended
to represent a complete list of the general or specific factors that may affect us.&nbsp;It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the
factors set forth in this release may affect us to a greater extent than indicated. Except as expressly required by federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result
of new information, future events, changes in circumstances or any other reason. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g915232g46j35.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g915232g46j35.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /W\S7C?
MBS]I'6?$^IW.E_#OP^^MS6\GEMJETI^PMC;S$%(,BGYUWED4$ CS%(SUGQ4T
MVZ^(.IV?A6WGN+6QG7[5K$L1VEK;E5@SCI(V<[6!Q'@@JQ%=9H>@V?AO3H[6
MQMX[:WC'"HN,\8R?4\=37DXE8C$S=*C/V<%HY*S;?:-[I6ZNS=]%:S.&M&K6
MDX4Y<L5NUN_)=O-[WVM8^0?BC\,/C=!I,GB3Q!XXUZSBM8Q')'I^I+9I&NX[
M=T=OM0DLP&[EL$ G  'B/A3XR?&[2O$%YJ?AOQ!XZU33;/=;75Y<++J=C:_=
M8A_-$D2,.#N.& /7!.?O7]J+3[KQ%\([C0[%+MKWQ%>VFFPO!:R7"P;[A-\L
MFP?+&D:NQ9B%XQD$BK.BZ+X0^'G@VU^'<.I:9#(-.-LEC+<Q1WEVC(X>4QKM
M+,Y$C,P49;>?6OA\=PE4ECK4,3.$8Q3YG-MN;;25[KHKOUTWT^4QG#LIXFU*
MO."23YG)MN3O97NNUW_P2/\ 9\^,,GQ3^!^E^)]8CM=.NG66.^5&/DQ212O&
MS<_=4[-^#G:&QDXR>^!R*\I_8TM$_P"%!6K;4:&YO]08+C@C[7,I'_CIKJ/!
ML[>$?%UUX9D>1K4Q?;=++MN\N'(5X<XZ(W*@DG:V. HK[;*\74E@\/.MKSQC
M=_WG%/7U_.RZZ?48&O-X:E*H[\T5=^=OU_/U.NHHJIKNOV/A;1[C4=3O;33M
M/LT,L]S=3+## @ZLSL0% ]2:]@]$MT5E^$/&VB_$'15U+0=7TO7-.D9D6ZT^
MZ2YA9EX(#H2N1W&>*U* "BN?T;XL^%?$?BRZT'3_ !-X?O\ 7+'=]ITZWU&&
M6[M]I ;?$K%UP2 <C@FN@H **** "BBB@ HHHH **RK'QUH>J:K]AM=8TJXO
MLLOV>*[C>7*YW#:#GC!SQQBM6@ HK(NOB!H-CJAL9M;TB&]5Q&;=[R-90QZ#
M:3G)R./>M>@ HHHH **** "BBB@ HHHH XGQ?X[\+_ R2^U37]6M;&XUZX$D
M<84O<W6Q(X@L<2Y>3:-I)4';OR<#FN'/QA^('Q:6.3PSIFF^"?#]Y_H\>J^(
M");R5Y JIY4*MY:R!MP 8RJQVY Y4_+O[4_Q(U3X>_MWW=QXBM[C5-.M+RQE
M18X& ;30$<Q0J[8Z&120P5I/,/RY('U-=_M@_"/Q_H$VBRZO=W%KJ47V-K6/
M1[]78.-H1=D60WH4.0<8(.*_/:/$%/%XBOA:E94(TY.*BY*,IN[NW)ZI-_R:
MZ[OK\?1SFGB:U:A*HJ2IR:LWRN3N]7)]+_RZZ[LZ6T_9[76<R>+?$WB;Q9++
M L$UO+>&RT^51G(-K;[(V#9(82!\C@\<5H>*]$T/X+_"'Q)<Z+I>F:#;66G7
M%R196B0KN6(D,0H +<#KUP*Y[X9?%2X\*7.G:'XDN-0N-/U1FB\/Z[J-I)9S
M:AM+#[-=)(B-'= *2K%0LZ#>N#N4;'[0-K_PD>AZ%X:\BVN%\4:W:VD\<[?(
M;>(F[N 1@[MT-LZ8/!+C) KZ*$L-]4G6P\?WEK:ZRYGLG+5N[:L[M---.Q[$
M70]A*K1C[]K:ZRN]DWJW=M6=VFG=:&M\$_!C?#WX2>'='DCABN+.QC%R(AA3
M.PW2L.!]Z1G.2,DG)YKG/CGKL?AGQWX NUMUFNGU=;5#G!59BD#G.#T68G'?
MIQG-5H/CA)\+_B7>>%_'%TBQW\CWNA:L+<QQ7%N\A_T:3:-HEAR%W#ADV,VT
MG+>:?%?XEP?%_P#:Z\ ^'-)OM]G8WB7)<+E': _:I"O0D$0JF?;(R.O#F69X
M>E@HX:@_?4H04=.924E:Z^5T]GHUHS#%8ZC3PRI4W[R<8I:73NDM/UV['T_7
M\]O_  >U?M6:HOCOX/\ P5T_5;FWTI=,N/%NLV,4Q6.]>28VUFTB@\^7]GNB
MN>\A/85_0E7\MO\ P5?F_P"'B/\ P=,:;X!7_3=%M/&'A[P25^]Y=K;^0U_Q
MZ+(]XV/;M7UQ[Y[E_P &?^K^+/V8_P#@HG\?_P!G[Q8UQIM];Z&U]>:8\NZ&
M._TZ]BMG9.VXI>'D#+*@S]T8^S/^#H[_ (*I:W^QU^SQH?P:^%^HW]O\8/C,
MWV:%],+?;],TLOY3R1;?F6:XD_<1E?F_UQ4AD4U\=?%'XW>&/^"7_P#P=Y^-
M?&GC+5+?PW\/_%&B7&I:A>RG"B*?0!.0!_$\E_;;%4<LSJ!R169_P2]AU3_@
MI1^W/\>/^"C'QBTUO^%??!&TOM6\+Z9=?- ES96CS6T"GH196RI(Q &ZXFC<
M<[A0!\,?\$4OV9O%-I_P7J^$OP_N+B2R\1>!O',\FL2V%UYB(=*$\]W'YJG#
M1N+:2(D':XD(Y#8/]$>O_P#!?CX;Z;_P5:B_9)L/!OC?6O&SZM!I#ZQ:+:G2
MXI'M%NY6),HEVPH6#_)D&-\9 S7Y)?\ !G!\+[SXS?\ !2#XK?%S7I&O)/"G
MAB9Y[R7 QJ&IW2GS6/8F*"\]/O'TK6_X-P+>3]O#_@X6^,7QXN5::QTE/$'B
MBSF89$,NHW?V6VB&>0!:W$X'?$>* /U3_P""E_\ P<7_ +/7_!,'XG-X$\4R
M>*O&/CN&%9KS1?"]E#</I(>,21?:I9I8HXRZE2%5GD"LK% &4GYS^%/_  >0
M_!/XQ?%'PWX1T?X3?%QM6\5:K:Z/9*ZZ?M:>XE6*,'%P3C<XZ U\"?\ !N/\
M,-!_X*-_\%U_B9\1/BE8Z?XDOM*M=8\<06&I1+<0RZC-J$,4;F)\AEA6Y=D!
M!",D1&"JD?T\P0):P)'&BQQQJ%1%&%4#@ #L!0!\A_\ !3[_ (+>? S_ ().
MII=E\1M0UK5O%6N0&ZL?#?AZUCNM2D@#;?/D$DD<<,18$!I'4MM?8&V-CSG_
M ()M?\'%GPE_X*1ZA\1)-,\,^+O /A_X7^'SXCU[7/$SVD5C:6X?'+12N0=J
MR-R ,1GO@5^4_P )_!&G?\%?O^#M'Q>WBRUA\2^!O!7B'499[.>/S;6>PT2/
M[':H4.5,,EU' S*PPXE?(^<U^BW_  =M^/[[X.?\$:+[1?#L/]GZ?XJ\4:5H
M%XEFODQPV@\ZZ*X7 "%[6-2.A#8[T >=_%G_ (//O@'X<\:R:3X&^'/Q/\?6
M\;%5OUAM].BNL#.Z*-W:8KC^^B'KQ7T!_P $NO\ @Y)^!?\ P5 ^+,?P\TFQ
M\4> _'UU;R7%CI>OQP^3JPC3?(EM/$[!Y%4,Q1U1BJ,0#AL<S_P:C?LO>$?@
MS_P21\%>--)T_2W\5?$R>_U/7-5BC5KB?R[V>VAMS)][9%' O[O.%=I#C+$G
M\R?!YTC]I3_@\E^W?"V.S30[#QU]JGFT]%%LW]G:6%U*7*?*1+/;W/SYP[39
MY+4 <SX;T'_AAG_@\*ALE7[%#J'Q6<0*/E58O$,+;$7I\NW4PH'IQS7]!7_!
M4/\ ;\\/_P#!-']BCQC\5]<^SW%UI-O]ET/3I)-IUC5)05MK8=\%@6<KDK%'
M(V#M-?A5_P '5WAMOV5O^"VWPB^,5K&T4.IZ7HVOR3*OS->:9?NC_4B&.U_/
MIZUO^"UW[4WB+_@OO_P5E\"_LT_!/5(-7\!>%=1.FVFI6DOVC3KR\8;M0U=F
MC.V2WMX59$8$Y6*0H3YX! -K_@U__P""=_B#_@H/^VGXH_:[^, FUO2_#.N3
M7^GSWR977O$<K><UQ@\>7:[PXQ@"5X0O$; ?JE_P31_X.!/AA_P5!^.'CCP?
MX.\*>,=!L_ 6CSZW?Z_K)M8]-:".=(1M:.5F!<.T@W #9&Y)! !Z[]I;PEX3
M_P""1/\ P1+\?:+X$A_LO1_AA\/KZSTB1L"6>_EA>..XE(P#+->3"1R!RTC8
M'05^;'_!G]^Q=:?%?]@/]IK5M4DN;&U^+$Y\ "\@P+BVMXM/D,SQ$]#G4E.>
MA:(?W: /:?B-_P 'HW[-WA+QMJ6FZ+X&^+'BC3;&=H8=5M[.RMX+X*<>9&DM
MP) AZC>JMCJJGBO7_P#@FS_P<Q?"_P#X*<_M6:3\)O!OPY^)&CZMJ=G=7[W^
MJ+9"TM(K>)I&+^7,[_,0J#"GYG':OS:\&_L ?\%!?^#<#Q1XT\6_!RP\.?%/
MX9Z@([G7)=/L4U""^M[7S&BDN;(E+V!D224L;=V10S9D8!37Z9?\$8O^#@;P
M_P#\%0O@;\1]9\2^$V\!^)OA#IJ:MXAB@NOM6GW5FT<S_:+=F"NN/L\FZ-\[
M<IAWR< '8_!K_@O-\.?CM_P5+UK]E3P_X/\ &EQXJ\/ZAJ6G7VO$6O\ 9,+V
M$,CSDD2F7'F1F(?)G>1G R1PW_!1K_@Z!_9Y_P"">WQ;U;X>M;>*OB-XXT&4
MVVJ67A^&(6FES@9,,US,ZKYBG 98UDVG(;#*5K\T/^#5N[U7Q]^UK^UE^TYJ
M5BVHZKX8\)7^H-'@NLM]J5S+?,%/4L18R+ZXD/J*3_@SG^ 6@_M+?MS?%[XM
M>.$M/$GBOP7I]O=Z<VI!9Y5O]1N)FFU!0V3YRBW9=_4?:2>I!H ^SO@;_P '
ME_P"\>?$6QT'QQX!^(WPYM;^2.,:K<I;WUI:!\%9)UC=95CP0=R(YP0<8YK[
M^_X*(?\ !2_X:_\ !-3]E8_%KQQ<7VJ:#=W,%CI-MHJQW-SK=Q.C21) 6=8R
M#&CR%RX4(C$9. ?QW_X/?OB+X1N_$/P&\*01Z?-XZLH-4U.\E0)]JM-/D-O'
M"CG[VR26.8J#QF%R.IKSG_@Y\\?Z]X'_ &$/V%_@;JLD\WB72_ ]KJOB"V*Y
MD>\AT^RLHCMZ[C)]M&/6@#ZT_P"(VCX!_P#1*/C!_P!\:=_\DU]T_L6_\%NO
MV=?VXO@I%XV\/^-[7PS!]K>QN=*\4/%INI64Z*CE'3S&1AMD0AXW=#G&[(8#
MR3_@H9\'/"/[$G_!MKXP\#Z]HFE75EX'^%</AZ*.6!&5-6EMX[..Z7CB;[;.
M)=XP2Y)[U^9O_!NM_P $3]#_ &\/V$=7\?>)+AK"23QA>V%CDL//MXK6S^<8
M'3S6F7ZH: /VJ_X*#?L]2>+;&S^(&FP137GABU>/5(68JUQ9*3)O4YV@Q9D8
MC&65VYRBJ>J_8=U#POK'PR$VCVMK#JT;%;YP 97!/R$'KMVX&..5/'<^W5Y%
MXP_9HDT?Q;/XH\!WD6AZU<.'FM)"8[&Y.[+,=JEE8]2,,C%>5!):OD<5DKPN
M9?VMA8*7,K3CI?\ Q1??35==>K9X%7+70QKQ]"*?-\2Z_P"*/GW77U9Z7XM\
M):=X[\.W6DZM:QWFGWB;)8F)&>X((P58$ AE(*D @@@&O&[[4->_9EU.RNO$
M"WGC'PS8QSP6NM!&-[I,,C([)<A?E*A8E_?$!<J1F,$*W9W/QMNO!-D6\6:+
M<:<8R09K>6.9)/F"@A0V0#D=>>>@[:?A?XRZ?XX13I=AJ=ZKYZ+$G ."?G<=
M*[L5+"XF:]G-PK)::.]KW]Z+6JOM?9ZIIZG37=&M).$N6HMM->]G'JK_ '=&
MCX__ ."A'[5.A?$31/"]OH.GW,EW8W+W<FH3!%:V1@4\A-I;=OPKD@@ )'U.
M0GJ7_!.GX-WT&@R_$;78WCOO$%K]FTR%U=7AM-^XR-NQGS2J%3C[BJ0Q#\>H
M:M^QG\+];UNUU";P9I*36K(\<,&^"URK;AN@C81-SU#(0PX.1Q7IU>+EO"^*
M>;2S7,YQDU;E44[72M=W2U2VWU=[JR/*P618AYC+'XV:>W*E>U[6N]%JEMOW
MOH@K\LOV/O\ @VD_X9L_X*LS?M2>(OC5_P )UJ4VO:UXB;0SX/\ L"FZU%+E
M2QN#>R_ZHW+,/W?)5?NU^IM%?='U9^7'_!;/_@VVA_X*W_M0>&?B;IGQ.C^'
MU[8:)%H&K6\NAG45O(HIY98YXR)HBL@6=T(;((2/!7!S]$^._P#@D7X>L_\
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M\+_$Z^N?&GQVTE]&UKQK<:$H6UMC#+"L<-BMP"%6.XN.#<$EI<EL*JC])J*
M/B3_ ((J?\$8=+_X(_? KQOX/D\:1_$F\\<ZP-0O-2?0AI2BW6W6&.U,/GS[
M@I\YMQ<9\[&T8R?B_P")W_!H1<_#_P"/&J>-OV;_ -I+QA\%8=2ED,6G0VD[
M7&FQ.^\P17UO=0RM"K! J.K-A06=B,G]JZ* /Q\_8Y_X-(?"OPW_ &B],^*7
MQX^,7B3XZ^(=+OHM22RNK%K6UO)XB/+^V2S3SS72*50[-T8.T*P9,JWLW_!1
M3_@WZ'_!13_@I7\/?CYX@^+7]EZ'X#72+=?"'_"+_:1>VUE>O=R0F[^UIL\Y
MI9%+>0VT,.&QBOT=HH ^8/\ @KQ_P3LO_P#@J7^QK??"&S\??\*ZM]5U6SO[
M[4?[%_M;[1#;N9!!Y7GP8S*(GW;SCR\;3G(Z#_@E]^P;8?\ !-#]B+P;\&[#
I7/\ A*/^$7^UR7&LFP^PMJ4UQ=37#2&'S)-F/-" ;VX0<]J]_HH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g915232g73p79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g915232g73p79.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X3&R:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIF;W)M870^87!P;&EC
M871I;VXO<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" @(" \9&,Z=&ET
M;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F
M.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/E!R:6YT/"]R9&8Z;&D^"B @(" @
M(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SIT:71L93X*(" @(" @
M(" @/&1C.F1E<V-R:7!T:6]N/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @
M(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N9STB>"UR97!A:7(B/D9I;&4@
M3F%M93H@(" @(" @(" @(" @("!S:&%R;6%S:6<N86DF(WA!.U5S97)N86UE
M.B @(" @(" @(" @(" @<G(Q,38P,30F(WA!.TQO8V%L(%1I;64Z(" @(" @
M(" @(" @(#,P+4%P<BTR,#(P(#$X.C X.C4Y)B-X03M%4U0@5&EM93H@(" @
M(" @(" @(" @(#,Q+4UA<F-H+3(P,C @,C$Z,#@Z-3DF(WA!.U-C<FEP="!6
M97)S:6]N.B @(" @(" @(#(N-B8C>$$[26QL=7-T<F%T;W(@5F5R<VEO;CH@
M(" @,38N,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @(" @(" @(%-I9VYA='5R
M928C>$$[)B-X03LJ*BI4:&4@<')E9FQI9VAT(&-H96-K(&ES(&-O;7!L971E
M+B!0;&5A<V4@96YS=7)E(&UA;G5A;"!C:&5C:W,@87)E(&-O;7!L971E9"!P
M97(@<')O8V5S<RXJ*BHF(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!C;VQO<G,@
M87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($)L
M86-K)B-X03LF(WA!.RTM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+28C>$$[/"]R9&8Z;&D^"B @(" @(" @(" @(#PO
M<F1F.D%L=#X*(" @(" @(" @/"]D8SID97-C<FEP=&EO;CX*(" @(" @/"]R
M9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z>&UP1TEM9STB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O:6UG+R(^"B @(" @(" @(#QX
M;7 Z365T861A=&%$871E/C(P,C M,#0M,S!4,3@Z,#DZ,#0M,#<Z,# \+WAM
M<#I-971A9&%T841A=&4^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR,#(P
M+3 T+3,P5#$X.C Y.C T+3 W.C P/"]X;7 Z36]D:69Y1&%T93X*(" @(" @
M(" @/'AM<#I#<F5A=&5$871E/C(P,C M,#0M,S!4,3@Z,#DZ,#0M,#<Z,# \
M+WAM<#I#<F5A=&5$871E/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/D%D
M;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+WAM<#I#<F5A=&]R5&]O
M;#X*(" @(" @(" @/'AM<#I4:'5M8FYA:6QS/@H@(" @(" @(" @(" \<F1F
M.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.G=I9'1H/C(U
M-CPO>&UP1TEM9SIW:61T:#X*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z
M:&5I9VAT/C0P/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T/@H@(" @(" @
M(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K6DI29T%"06=%
M05-!0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML3D$K,$%!04%!
M04)!05-!04%!045!)B-X03M!44))04%!04%104(O*S1!1&M&:V(R2FQ!1U1!
M04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='0F=G3$1!;TM#
M=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%417AW8D=X<V-(
M>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(>#AF)B-X03M(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&8O.$%!15%G04M!14%!=T52)B-X03M!04E205%-4D%F
M+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%104A#06M+0W=%
M04%G241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G8TE#46],14%!
M0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%1T4R16EC6455
M37!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I25&MQ2WE9,U!#
M3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P5G1.5DM"<GDT
M+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7-799,U(Q9&YD
M-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E66U:)B-X03MQ
M8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"455%0E%914-!
M341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO8DAW1DU(4C13
M3D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X9%5K=V=*0VAG
M6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-5%4U4%)L9%E7
M5G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F2#$K9C-/16A9
M84AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K<4]K<&%A;G%+
M;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X03E5-'$W1EA9<3=&6%EQ-T98
M67%K)B-X03ME<V5E9DIU:E,K:'%M=%=6<&-K,$9T2D]N<D4K06E"3&XV0FEQ
M6&8X<DHP=65V-DPP<E=.5D$V4&(V9&-2>&LK0WDS4S(P6BMH<U97)B-X03LO
M=T-++U!&>'9:95-P-#%0,D<Q1RMS-V5V>E="<GAH.3)+=5=8.#)R:T4O5CE#
M,'EV,F55=#-F<W8K<T%L:T0Y1%EQ,%!,9C5I>FHO)B-X03M!17)Z:W1U5%%K
M869P:T5D3VUW3C Y-31(8VIV:7$Y4$E.,C8O=T-M*V$Y9'4R22M):31G=&A8
M,D9R1$)4-SA664YB5R]K1S4X,2]O)B-X03MU8E1.8W9B3F11:S!L9DU&>G%L
M.4YB;E55:DQV05EZ9&,Y=4)8;55P>49-2W-V,&8X;B]**VPK8U X55%7.6)U
M0TE1-F9#4U-K1E%2)B-X03M*2GE9<SAK:CAM*TIJ<T]G<G9G5FTK2W5X5C)+
M=7A6,DMO92LQ3%1R0TPQ<C8V:'1)=CA!9FLX:7AR=#=S44U6638O-7 O;"M'
M6F)F)B-X03M767(Y:TY'6%0P;'9Z6'=P87!-8U973BM91GA+0BMJ=DLR=5AR
M3G-N2S%J<WAV.$%Z1SEL=&EO*VI&5D<W.#-E94EB85,V8GEP1%I7)B-X03LP
M4S@U2G13,5<R=#!24G5423!+6%-Q05!F*W5+;U0X=&90.$$U;S@T6%8W4&,V
M1$9995@T95,R5W)26$UK>5A59UE$.7=S:TU$4$=")B-X03M8.3510W5W<G92
M5FXR2W5X5C)+=7A6,DMU>%8R2W5X5C)+=$UY<7!::4%O1E-4<T%":7)'3#,X
M>F9*3G1C=EIX86M.4G8P2'A75VU2)B-X03MY-FA/0V5G361Q<WA5+S8Q3591
M-3@R96,Y45ER;W9L2V%+26M"8GI78FE+>51F<692:2MT6$<S*U5I-'$R9$4O
M36DO3&98=DUD='!5)B-X03M*,D5/:S)185%,,R]!2#DT,#1R-VE%67$R4'EX
M,$=E:#%E.#%05S)(82]V<#)I*VU#2F]B9F8X031X-'%N=6LK5R],,FI2:5!3
M9$UT)B-X03MD4%%#9T9T1$A&+WA!1$95>'A6,DMU>%8R2W1->6]P6FE&5E)6
M;4]W04A5:S1Q*V9T3S@X*U1T3W8W1%%*=%-I-3)8;DA5-WDT.4)7)B-X03MU
M2&$S0UA5,$0P:%9I,TM384Y0:#=G.6AH5C9L1"M:,FLS9%1P=6LV,69O3VMK
M96U855-(875Z6$MW3#!W2VE)+T]E<GES,V\K5'1B)B-X03MD1G X8DA425%A
M*T%M=EDR+T1&5E(O4%=M,DYU6B]-540K5S%*26E4534W3&Y+9'%E:W1R8UA*
M8VUT04)V=#!X5D1P-35V.$%54EAY)B-X03LW-65V.5%J4#)B>3=586)B2#-R
M8SA:,D(X56AB1E<O<2]W0V%&-E8Y4S@P:E)O=7)P0D10<45V>45S<C)A1"]K
M56-682]W04(S3C!V)B-X03LK-6YZ3')';V-J5U-+2V1D4&E)+VQ!<T5T<$%V
M>F-N,WA613)8-6,K4F)39C9X2&]D<$QD8F8V5F-X:35N,B\T=&XY4U0O:'-6
M6D1&)B-X03M&1D9'231K5T].9&Q244%".&=-5E%M=#9Z<#)I851D-G1Q56]H
M<V)+3G!:-41V4E8W061Y5'-",T]+<TTP,WDQ<5AN4G)F6%!/8V)2)B-X03MA
M6%54858U4V(K-6I7=%DU<B\X03,Y3U)1*VUF9U1W2G%C5EHK:4EI2VE+1E)1
M07%G54%!,D%!1TMT-'$W1EA9<3=&6%EQ-T9867%X)B-X03M3+SA!>DLX=G@V
M:$QP5VMR3C5G,6U%9G9D4#!T0DU9>E=N-S99;$E)9"\X069K9WA663!0-6TV
M<U%7=4Q(>7AA3C%J:%4V;&4P-D0Y)B-X03LU2C96=$=E+SDS25!F1EA**U=0
M;"LT*TQ8<#=Z>DA+844O<%<T96%'=EAA,%0P-U5B+SA!1E=+<VYS9%!S3$-!
M5SEJ8E)7;'5V,EE9)B-X03M%5TY".&Q505EQ<C1Q9TY!,7I49&4P83 Q:E1*
M1$Q96#!9;'0U1U5O4W X5EE!:D959FER<U9D:7)S5F1I<G-695EA=EEA0G)V
M;C=Z)B-X03M$2#4P;E8Y1#AV5W1H4%DV9&13;4MX0S-#>4Y*8WI*5E5L4'%2
M;$)Z<4)4<&ER2%!Y,G103#EZ*V5'<6%Z;RML+V\O4G)Z4B]5,$YV)B-X03M2
M1G9(36M5:T9V3F-146=,>%)I04%3;W%.+S)S5F5Z87AC-FAA-E9D6$=M,F8V
M478T;VUA,7-F55-(,7!!4&A4,4AO<3%08S1Q.'0O)B-X03M32#5M-FY1*UHY
M2SAW5UA5='!V;# V6D1#2S!O1W9(=EAU2#(O:TUF>7A64'1!5%)T25 Q<7<X
M:6%P8C-R9T-3-VU3,&YU,G!T*SAU)B-X03M(=35:1RML>FEQ8W(U-69K-&PX
M=6$Q0T5.0WAT1FM(5VAP-E5K:% P67%Q9CAR03AT26%88C-69U(Q3CE9,VQQ
M;S<O8FUI4D0X=S%-)B-X03M66#)8-6<K4DPV47A7;FU(5'!:;%!&;U)D42MO
M0T13:%%T>2]$1E4O5FQ:47EK1E-+9VIC14A&5SA667@K669L<E9V34]H45=E
M;'DR)B-X03LX9#%B,S%P9D),=U-.8GEI,&U78C U4D@X4E9I;WA62S$P9C@U
M,FLY5B]-;6IP56)W3'!K>E)Q9EIJ8VAZ.4IX5G0O*U8P,D5B3W P)B-X03M,
M6%%P<4EG='IP,')#;39Q>&$V:G(T5G X.%969DQN-7%A2F8S3#96<G-495=0
M36-0.3EP1W!/<49H,F$S;5!'3V1$-' Y,DMS<W5T)B-X03M5,'DP9T9X9#-C
M3G9B:U9%,'-I26A(:GE99V0X5EEP8R]N1#5"4V,R,6AF=G)D,S)T.4AG;3%&
M=BM#=&QK5#<R>%93:B]/8GE22&1R)B-X03MA879*9"M8-7!.-&8P>EHS1F=J
M+T%/<DI-:7 Y-4=+<%(K8EAN1S!K.')1,U!L>GI(0GES-WE#-C%+,S V*W0T
M-W4T<T4U979&8G9Y)B-X03M0>&UO654V,' S>%9)4$QF-7DO;#EP*W,V971N
M-75U8G)1=%)G;48S839W6G!:<D]E3VIX=#E9;%5Y56-C:TMS>D-T0W V,59E
M:#)F)B-X03LU<V9L,V5K0WHQ>4,T<6%$,&A).5-/,W=Q8U96669Y>3AH5S9S
M='!O='9:0FIY8C9O1W1Q;G@O8VU08V1V1$96=SAG-E1'-64P=G16)B-X03MT
M0V8R63E4=E=1931J;&QL:D@P3&EQ-E114$Y6<TLV6C5L:VM),U=,5DQA0S5J
M*UA+,T9N3%0U=51I<6ED8S@W-F18.4ME6# Q1T5F)B-X03LX9D]J6$-U.5!&
M<F$W*W)L865#4U!I<2]2=GI(.'%A<G)2,$=/-&QT3F564S=A5&5W4S(Q>'A#
M.&E1<VEQ2$A(97%%:6U+<U@X<39P)B-X03LU<#AM850O:&$W.')A:'%J5TUS
M>6%49F%B-D0R,7AB4$MZ>&5O.'-S6#%D;$0X5U9H5&)B1E5X2&Q,>E8U<FY&
M>#4P=69Q3VM"=55()B-X03ML8E1P5S1-06%G,S$P=D9P=BM-86-5+S%S5EA.
M*U9.<G!K9VXX;6%V9656-4YU5G!!4F,R1"LW,FQX>E%(,U%R:7%+:&DO3C(S
M0FIK)B-X03MU3D(Q0E)S;'<P9#-A3V9D;S%A-%=V>6)&5DYT2R].>3EB+U-.
M9C!R4TEW3VQH65-836A0*W9C>D)F.$%K;FEQ=V53=GI":5!/2#AW)B-X03M,
M='!#4UI&=4Y0<TI)>G1104MK8U1,5#)B1E<O.$QF;6Q)44IF4$U-8V9C,C)J
M=W!*.413>GIR+T%-2FER2'1E+TI6;C%+=SAZ<F1Y)B-X03ME869-96UV5U,S
M,3$P3G1C=V9%9E%2630Q:F=+<S-/33A#;V(W45!52W-H.'8V9#5P,51Z;79M
M9EAD3&HP5S-S=%!K,"]4<D0Q-#=M)B-X03MD;75*635:6EI7:4AP<'@Y14MQ
M<7ID5&ER3CA69&ER<U93+U5V35AL+U,Q3&%N<61P67%V,FIC>GAW9V0Y*V),
M:7%29CAR5#AM5&)A)B-X03M:8WHV>DE44E8P<3%U8C!%.5 W>4-.-'@X,EE$
M1E5V,64Y,7IZ1D<Q=D0U1&EU65=(0EHO36-L<D9$.'I$1TPR67)V,$M$1E9B
M.'1F)B-X03M)3V\K5E P:DQD6'-:5%5(4C1T1W-6;%14<E!G0T0Y6%-:-4AQ
M+U9J<U!B1E=B-'$W1EA9<3=&578Q<GDW;T=U5S1T.5HP-C(Q1T%B)B-X03MR
M2&122DU!9D9E64Y$.'-64T=Z+T%#:2],1WIN.65$>7AP=VQ"1$%V06MG0DA1
M9U-"9U!O>%9L3G):,FQP14EB5T-/,VA'-&II5E57)B-X03MV>55!67$S8S)T
M=&121T<U:%-E1G9T4GE+2%4P.%$Q4FEQ5DAY5C5.2DI/9S9C4V1Y5&%19C@P
M67$V,CAL*U1R5S8K=5=U9S9D0F1K)B-X03M53GA&85%*2E1W-7%G8D95-%96
M5E%Q9T)12T%$64%$1E5K,2]5+TYT;F0R-F%,;V-/<3)J<7AU2G!,,%=R>'-/
M9T-.1DE(0CAE47A6)B-X03M,5')0-6YY:W)"-5DP-C-",E=3-C%:.79%;$EB
M3U0U8DYI<35R6#@P<G!3:C,K:C971#%K:'1R;3EK2"MQ6DIB6D%F;7 K5TMQ
M4#A!)B-X03MY<G$V=G58*TE032MR-F]R+W="-6)25$IP,756+VPT5TMW4U4K
M8VAX5D].03AL955V3'A:=$<P;3)S<&YR-FQX2$=05V5U-35Z3E=2)B-X03MV
M.6LR2W Q:7)S5F1I<G-69&ER<U9D:7)(4$Y(;$Q59&)U<F5A,3AY86YO:V-+
M;$I)3$)O1E-4979)*W)&26588G)4,GA63#10>35V)B-X03M9,S50-7HX>%1#
M;$]$,T9Q0C@O9W1K4#0T<7)F.'$Y0F-T3#5L,391,$%!*W9'34-N=$5K9C0T
M<3(S-6(V6DE16F18,3)19U5*+U1&)B-X03LO1T-09%EP55@W:&ER:R]+=GE/
M4#<R>6YU=#8O-EAE,W0Q+WEF;6MX5DAA6C5!.&IA5S-,5'9,*VY7<C%".5-+
M,6A6-FIC9D=&-6)F)B-X03M01E4K04%!049!3F=":7)S5F1I<G-69&ER<U9D
M:7)S5F1I<G-69&ER<U9D:7)S5F8O.6L]/"]X;7!'26UG.FEM86=E/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@
M(" @(" @(" \+WAM<#I4:'5M8FYA:6QS/@H@(" @(" \+W)D9CI$97-C<FEP
M=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @
M(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P
M+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@(" @(" @
M(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP
M+W-4>7!E+U)E<V]U<F-E179E;G0C(CX*(" @(" @(" @/'AM<$U-.DEN<W1A
M;F-E240^>&UP+FEI9#I!0S$W131&03,W.$)%03$Q.#E&14-%,40S,D$Y,#1&
M03PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D1O8W5M96YT
M240^>&UP+F1I9#I!0S$W131&03,W.$)%03$Q.#E&14-%,40S,D$Y,#1&03PO
M>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C
M=6UE;G1)1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X
M/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I2
M96YD:71I;VY#;&%S<SYD969A=6QT/"]X;7!-33I296YD:71I;VY#;&%S<SX*
M(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI
M9#I!0C$W131&03,W.$)%03$Q.#E&14-%,40S,D$Y,#1&03PO<W12968Z:6YS
M=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^>&UP+F1I
M9#I!0C$W131&03,W.$)%03$Q.#E&14-%,40S,D$Y,#1&03PO<W12968Z9&]C
M=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)
M1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X/"]S=%)E
M9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIR96YD
M:71I;VY#;&%S<SYD969A=6QT/"]S=%)E9CIR96YD:71I;VY#;&%S<SX*(" @
M(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @(" @(" @/'AM<$U-.DAI
M<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D$Y,3=%
M-$9!,S<X0D5!,3$X.49%0T4Q1#,R03DP-$9!/"]S=$5V=#II;G-T86YC94E$
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 T+3,P5#$X
M.C X.C,W+3 W.C P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S8@*%=I
M;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA
M8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I!0S$W131&03,W.$)%03$Q.#E&
M14-%,40S,D$Y,#1&03PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @
M(" @(" @/'-T179T.G=H96X^,C R,"TP-"TS,%0Q.#HP.3HP-"TP-SHP,#PO
M<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E
M06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO<W1%=G0Z
M<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG
M960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T
M;W)Y/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C
M<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z:6QL=7-T
M<F%T;W(](FAT=' Z+R]N<RYA9&]B92YC;VTO:6QL=7-T<F%T;W(O,2XP+R(^
M"B @(" @(" @(#QI;&QU<W1R871O<CI3=&%R='5P4')O9FEL93Y0<FEN=#PO
M:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4^"B @(" @(#PO<F1F.D1E<V-R
M:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@
M(" @(" @(" @("!X;6QN<SIX;7!44&<](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]T+W!G+R(*(" @(" @(" @(" @>&UL;G,Z<W1$:6T](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]$:6UE;G-I;VYS(R(*(" @
M(" @(" @(" @>&UL;G,Z>&UP1STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+V<O(CX*(" @(" @(" @/'AM<%109SI(87-6:7-I8FQE3W9E<G!R:6YT
M/E1R=64\+WAM<%109SI(87-6:7-I8FQE3W9E<G!R:6YT/@H@(" @(" @(" \
M>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD^1F%L<V4\+WAM<%109SI(
M87-6:7-I8FQE5')A;G-P87)E;F-Y/@H@(" @(" @(" \>&UP5%!G.DY086=E
M<SXQ/"]X;7!44&<Z3E!A9V5S/@H@(" @(" @(" \>&UP5%!G.DUA>%!A9V53
M:7IE(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T
M1&EM.G<^-C$R+C P,# P,#PO<W1$:6TZ=SX*(" @(" @(" @(" @/'-T1&EM
M.F@^-SDR+C P,# P,#PO<W1$:6TZ:#X*(" @(" @(" @(" @/'-T1&EM.G5N
M:70^4&]I;G1S/"]S=$1I;3IU;FET/@H@(" @(" @(" \+WAM<%109SI-87A0
M86=E4VEZ93X*(" @(" @(" @/'AM<%109SI0;&%T94YA;65S/@H@(" @(" @
M(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:3Y";&%C:SPO
M<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP
M5%!G.E!L871E3F%M97,^"B @(" @(" @(#QX;7!44&<Z4W=A=&-H1W)O=7!S
M/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(#QX;7!'.F=R;W5P3F%M93Y$969A=6QT(%-W871C:"!'<F]U<#PO>&UP1SIG
M<F]U<$YA;64^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P5'EP93XP
M/"]X;7!'.F=R;W5P5'EP93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4W=A=&-H
M1W)O=7!S/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F
M/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D
M9CI0<F]D=6-E<CY!9&]B92!01$8@;&EB<F%R>2 Q,"XP,3PO<&1F.E!R;V1U
M8V5R/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\
M+W@Z>&UP;65T83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@
M96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$!_\  $0@ )0#_ P$1  (1 0,1 ?_$ !X   $$ P$! 0
M           $!0<( P8) @$*_\0 ,A    <!  (! P,"!00#     0(#! 4&
M!P@ $1()$R$4%2(Q01<C)#(S%AA#435"8?_$ !<! 0$! 0
M   ! @/_Q  O$0 " 0$&!0,#! ,          1$A C%!46%Q$H&1H;'!T? B
M4I(R0N'Q Z+B_]H # ,!  (1 Q$ /P#]_'@!X > '@!X > '@%8M$[2Y+RF;
M4JM[Z)R.(NB8'$,_:W6&G](7^V;XG_1YS7',O>'PD.()F!E +B50Q$Q #G*4
M14F[E[=;C0?^^*OSZ9CY5S?V9KP_C[ Q7-UQQ]B^ 1 "J1\]U.IS]6GS53V!
MD7[::4CUTQ!9!VHB(*>!&;76?$_.<(3[]VK81$*3P O6@/Z^P?H;J7(:"!0,
M ^C/28-']4G0 H^ON%; ^,'Y^ '$/7@0L]X6]TM3VO/A"_4QLY5BJJ\+XF*@
MA]A5%'?.GC-BB ?+[B*BO(Y79R>Q @@JU(<2@8Q"@82 'TZOFEGI:T[G@.>>
MT)_V-P^H5.US[@^U"X-S#A5'(G['^16G^-S/II5(H![!/]2J]4*'H3J*B B8
M)64[M^D"\.*7<H4I;YV)V]?@]""@CM<)DAE1-_O,8W-] Q,4A-_8&WV"I_\
M@*EZ#T$Z+SYDYNY%$<9;#MS&A+X/V#8LNO&PZ]@^2].:CVCT7I=.V#9<&AKS
M-:K7$*Y9>EK%>X:NQZ.8:6RJ]IG:\E5K6[HDXV9D8)+P)ID:<JLI.$X5E*$X
MBY15.8]9B]^'?2^Y-P+IRU=9TFBHI:I*5PE)I!CG5"#R^GKL4$K"VK+)19PX
MD;5<) 9%U9;W97LO95(EXG489U"U=!>,>B.TVHPO>KUVP6!T1\&0\ / #P \
M CG1=AR/((XLQK6IYSET0<BBA)31;O6:3''32_Y3E?663C&QB)_^0P*B4G_V
M$/ *V)_42Y&EB_+/]'G]O*8_VD5.<,BV;I)HX.(@!3(R>$Y]H,5^F,(A_KU7
MR<<F4?NK.TT0,H O"]MVEY:,"O8&BS"WV,YX/[(NZ1_8IS,S$X-C4(0@@(D6
M=H;CO&=W-(AQ^("DUI;Y\G\O\UF02F  C5=_1,T+0>K>MLYI]CTB[\K<^8SF
MU4C#RM@NG1?=47G<5"M"J)I%/*NL]YZVB+:G.HJ1-),DNN9RX,FT9_J7:[=%
M46$Z)MO!*S?W^0.?T_\ J+IWJ^MZ!H6X\O0G.V<HSC1AALZVT"YV26V>N%4D
MQ?:&WJ&@Y!CUVJ%&DFI8-S2W=RJU?LEE;/7K]:K14:G'.Y$+22<)S1-T2B<*
M-W8ZG0KP9#P \ / #P \ / #P \ 1R$@PB6+N3E7S.,C6#=5V^D)!RBR8LFJ
M!!46<NW;DZ;=LW13*8ZJRRA$TR )CF  $? *9R'U#.4E9EY5\YO\MT+;&*BK
M9W7>7J#?>D%8Y^B/I2.L4_CE<N%-I3I,WHBXWJS5ELU.8I';A QR 86'MNTN
M=<-1I#>.T-"=$0R?BEMG$"O^"W3K;<J?1'9&_P#:1C,PP5AT18I,3A_)O#6V
MQ9C(F*/J04B5 %(7SY?Z%A*]S7!>KCU,P8;VI?#&/J/:\=G$<NH83UWD[ *7
M2W:3/V(%8.[WT-*=+2+]94@?%U,P-:H[OT<PQK>*7(FY 25E.[?I'SNH3^GM
MSK,)D_Q:-L'1JH_EVWZ+WG7]:J3\PF$QQ7R>PW$V,-2JB(@LA%9S'-EDQ!%1
M R":21!>)X0MDEWO[T=46FH&79GD\(G6LLSNBYK7$@("4!0*C 4V$2!,OQ3!
M.*KL?&L2 0O\2 5 /B7\%]!^/!DWKP \ / #P!LF9J&KL6]F[!+1D%"QJ!G,
MC+S+]K%Q;!L3U\W#U^]50:-4">P^2JZJ:9?8>S![\ _+)S'WQR54I[C[GP=7
M5OMMY=["^I!;K3"X;0-*WV:>PR5IZ@SO,+@WA,/IM^E)6&T.J] ,9V.E(YF\
M;.7JZPJJE%-10LWUNGXZ=SI:LVJMTFS9O:2K%*O"'31Y'<**[I2M@ ?/.0>Z
M;JB<QRHK2//#C$BK?$?0&!/IRT8<X134_JFH[1;IF+_+Y 7\^4SPQ>[/5/Q)
MM37I'<WOHZ?T_NHHY(Q2B7]\T'B-LX]B;T/W$(?KB>*F3X?S+[6%7V($.BF;
MWZ$A9KO["R5[)RO/V:*>]&'!+I(JG+7<BM=EHM]V:V-R>O\ 5U/-,.M6J6.T
M$/\ (OVVM;;2\B'HYEF2) *=0(RKJIA;RE SH](;CHB0&PGD;07$>O\ $S"\
M=-V)ES)3'J!P$?N)U9>%TOHR/<I% #F8VGG^K@H91)$KU,_ZHS,(6+7*N6RQ
MP;NV/@43NRY&*>S]!X3CD6J406A<:PR=O5O9F-_46NH:[HJ]4=@0H_%('//Z
M'I0OWE?NIJ?I4PE95U=.BA]V>2\4P5@$5-@Z'ZVVQ4_Y70GMXG<C@'?L!*=&
M0I?+3' *1*L3E$2'C)BN2$>J7T+ALLJ *>!-]%72?,LD#/\ CGE#+)+]\S_G
M'%JU93'*HO;V><U9:[/EB>OBXE+L]C'5KE7)?0>G,E,.G    "GH \"7$2XR
MFA9$   ] 'H _  '] #_ ->"$*=#;Q3.;,GLFLW=&9E&4.I$Q$!4ZLQ_=[IH
M-YM4LRK=$SBBP@*(FFKG>K7*15;KL?\ =00,_D$W$@Z8QC=Z^;"I2X^4JWR1
M6#,.4K5KEKK/1W<Z<1>-6B7B-DRKGIJ]+8,!Y54,0QHU.N12R",9J>X1K=7[
M=DWNU1[IZTEA>,LEC*'5_DE+ VKE3-XOV6FTS".A7@@> '@!X > '@!X > 4
M4>]_Y':[=9,TYD@;EV'I-1>GB+='8&A"2.<4*9(4GSB]&WRU3-9Q*K2S/[GW
M9*H-KQ-Z4W;(N%&5#DG"9&BKYT-<+2ET6M[V5[\:BXU*[JU8?N7+8<MY6K3H
M@@>K8!5D]KU=J0_]#AM^W0,?FS5P"7HJ[!'EV7(U=&.+6R/D4DUE@^E8-[T6
M."G3]PLBN!>=%G+>5U>)N?3=@0<$?%ENI= M>[1B$DD8#HR4'G%VD7N/TIXW
M4*"S8U!SNJI-5_:[9%)81.(G$\*;4\>I<&*B8J"CF</!QD?#1$<@1K'Q44R;
M1T<P:I!Z3;,V+--%LU03#\$102(F0/P4H!X(+C& A3&$!$"E$P@4/9A  $?0
M 'Y$1]?@/[C^/ (GP;::5T;BV7;SG)Y0]$UVCUW0*I^]LB1LTG"6:-0DV2$O
M'IN':;*3;I+@W?M4W;I-!TFJFFX6(4JAA6H;3P<="6#G(F0RBABD(0ICG.<P
M%(0A0$QC&,80 I2@ B8PB   "(CZ#P02Q\C'RS)M)13YG)QSQ,%FC^/=(/63
MI$PB *MG38ZB"Z8B @"B2ABB(" #^/ %G@!X > '@'%&V1G+]AZR[OU3ZA<U
M0+!0.9K'@47A%7Z)>0TCBV89K<\ J%M7O--SRT"O4Y72]$V<NO5\+:I!S-[?
MC0XVI5-R@C'J1[@;4Q95F5*<M7NM5-\))4NO9%'TX:["G^J#WIJ;/([;A])V
M_$.>M=YFHMQAV-3>O\VF/W')==TAKG"*R,EE*^DV?!<IF'U*L</%6\\$SI<Q
M;8N DW:<!'A:_194IM-IQR:6L<3F*3R.U^XSVN5C)KQ.8-0*]J.P,(<1H%$M
MMO+0ZS/3SAVV:IEG+4:/DQC(R.;KN)=T1)F+B138#%-G#)P^2>MQE1-9C&+S
MDS&UGNW3HYHZ["R3L.VR2J13S66<D[ES!S5@K==8PJ*,(6<KW4%>Z;M3%LF)
M(]XZN^U-HBR)H'>C0JVA(.H9,6E8:B:-RVO]8[>$6@R23+A+.29Y']*3<,U"
M;6!U87E'E/I_1LO:'Y?0#)VN>+V&QF[5++#_ #7F+$^DI1R?Y*.72B@B8P7W
MVESXO8EYMT[J ' 9O@_KZN- 'T=\YDN/K*1, 'T)QC\^ZVN<XJ !_+TWBECF
M#\%()OX^"0ON3_+U2W_F@_!UQF+,13LM4Z#IBR1?F\-9>7NB"0T> ![$7ETA
M\TF*$4@?GVJC:ET0]?\ )Z$!$(VZKQ?V&*,[_P"(9.90K0]78)"6AVJ*+.IW
M'3*M1+:\5*<$S$95:Z2,!8'8E4$I#?IHY4"G,4IA 3% 0AWPXSPZW%MFKIL]
M;-WK)P@[9NT$G+5VU63<-G+9<A54'#==(QTED%DS%4253.9-0ABG(82B B(9
M_ *4=G<\;)NP<ZV'#='SK/KS@&[EV)D37*%8])SN?^]DVJ980)>J52\YU,/Y
MBJJZ66[5$0M3%@G9J[&G?E.B &3%3B94RHHX=Z='#RBZYD;H<\_4D!0SAU]2
M+.%55!.<[-MP?4V\0B<Q0 B;-%;>7<NFV3. F^#R<?N3E$2B[ ?1@%FS]KZ_
MP)I*&^K+F+%=] W[B7K-NP35??\ 3=CS/6.2[M-$2 5#0L;<872^BZ0E(.B$
M^Q&O9.DQ,>1TH09)P@U^;A)7Y\[=Q]+S7-/T3CJQYQ/ZE6!WR4#,=U74XVZ:
MBT_MVGG'I.9@Z/:P<I"*:TIF=KD';2E;?17:I%582[YE+S3%\Q*5:290CS[\
M<W?(#LN]56:]<GHRQV@=9\LY1"C8]/Z2P?/8+X H26NFN4&M,%BF_P!@-W$O
M/M$W*BHB!44FXJJK'$I$B'.8I1$ANY-\BLB7U0^=K<J9'GZG=(]9%3,8BLUS
M=SOI=SH!#AZ^!$]BL4/3L7>'6 1,D2/T-V<2%,<Q2D^)C"\+Q:6[2?2_L,A/
MJU<H5.R(5#I)MLG%%B?K%1@P[ R:PY%3['[)\U5('74S6+%GY6X_Y:Z0:,FY
M*<#@1 Y4EC)APMW5T33=-+^J*'?4M^HCRLXC,#UO.NY<RU'!,JNEP==28%RM
MWC4,AWK1:59:G^VU6W4.:S#9<_T*X/\ )K$@><<Y%!6Z(6T)C-. 32D'\''M
MA&K-FU5<+3=$W9HG.,JDQ$YTN;&#EOZUWTU*KJ\AFU#[0T2[X-9,MC[K5F6V
M170^BWS+M+9VA:*L&=,[WHM8L.M7&.LL'*1LZPB[+.WE*LO*Y+IUZU! S,9!
MQI?)GU#_ ,=N)=F*Q>J\IIX?GL!3N]N:-!0;N:1.:K:4'8F!HM"\S]-/DW0$
M1.N<[<R6/B"Z1$DSG,JE\DB@'H3@80 1B&LNJUUT-D-P[Q<*J[E/DCFAJ\<'
M%1608X9F4?)&5'^JQ9)C6&[]-?\  >ETW!%@_L</ XK6;ZL3AQ;@314JM=C]
M2H)"% A666]%]%Y1$ 4!]E(:"S?5:M"*IE-Z,"2T>HE[ /:8@'KP)>G-)^5_
M8L=X-ID(D0<PZEUZN@T(/[?7=&BZ!M%.45$?8'G'=IJ[#999+\%(*+;:HDWV
MP-\%4UCBL @P#<NT,\34&W8_E?1,6V$/<U@MQ5R._P E[]_Q9X[N4L^H;0A0
M+[,N]ZE^9CG*F5I\2F6\%H\6MZKJJ]C0\5^I-S-M/0$KR8@^NV=]1P4,^L4S
MA>A5)8MCCX.,1*L_DS7&BO+UD+U!M\OM*)QFD/G(K !$T#_<2%05V6E,4;A/
MOO=F5YYYENR.,<NKW(K#A^X;ZPRIS/U;&]PSK8L*I^06G+23<C(4-SI*.C7Z
M%U+-[= 0$A&URX0\#F>CL'<A$NIFH/YMH\)&,A7PMSQ1-Z<MSI2(YJA+;/CC
M3.DY<;?]0NWUB_U8%".*OQ?ESB<+RY4Q*?Y)KZI(S#6"LW5=G3(1(!7TB K>
M5,5Q5<0F-LI--"<$24OT]7?AA<N5:Q,4%#_Z:&24F8=VOCS0-0X,LK]P5[*1
M/,SVKQ^)61ZF4I".+/S/?*Q=,$<.#)@=-Q,5JAU2U.2J&^[8Q$"^@XGBE:WO
MZW[7I91(\*4#ZG]=25CZ_P!-\9Z$T!4!8S>E<E:Q7+0DV HE^U,AGG532L3+
ML1^"AGL57JDW,8JA"Q:952"W";.3_+_GYV$SKGSZ@-Y$37WZA%>S5JN)OO1G
M+/)-!ISI! _\3-TK)T?=>J%550+[]2",%&*@<PG2;HB4GQ";*_;.[?IP^<<:
M#9_V+;S"?8>4?ZHO=$;,D^8O%KS'<B:="21CB)A,M79[EMHU8?S'X_"$<Q:1
M$?\ +1314^*Y7/G3VCL25]JZVO?RF9E>1NRYPY&MJ^J5N[2%,3[+UMF//7(=
M&FWB/]!,6Q6+'-%<1SLX?[G46T9?$WLR"2/X !9L_:N;?NOF!"%K^E95\]UG
M/NQ,6=2'0?7>7,I2*=37;^EW'5FNKTYZ NFM5B[5)LK)%<Y6VJ3'ZB7S70,B
MS!&,K2L[<H27I$S$7-\XBPXJ<+I9<78.Z=:7IM32M"RF!Y5T19.D[IU?TC5<
MLRV4>XE5<+S+(\UODWJ[ZO5UM<IJ_7:R7[196AYNP?3UCG'-<81=<K5;=PT!
M%UT[@UBEGLPX*U$;40IOFO;%ZE]O! \ 3/'K..;*O)!VU8LT""HN[>.$FK9$
MA0]B=5=<Y$DR  "(F.<H  >Q'P"L%W[EXRSAV2-NW5?/D#-+',DUK;C6Z.XM
M;]8GOYH1E38S3JR2C@OH?DWCHMRL'K\D\%AY/HS34.[,]M ?#'\=ZLW!P<X)
MME:;S;I='K+\QO?P/&:;O\5C&2238P@ "]8WY=BG\BF6<I$]F $M4EJUX4OL
M:5?9'LSH"OOZDSY!YTSJG2J9BKK=C:+';!((^_8)?N&"XC!6ZC6$I0'YKIFZ
M2A0(( BBHX!4RZ(JA.]O:G=W='3H;5POQ:CQA3] @@TI[=7FF78]\DJO7:TW
MS'!,R>JLDV:U8Y[PV/E['&9%2'*A#R<C"H62P.Y6:76DW\HH<444!&Y?;-\W
M27_5R+R^"!X > '@$?Z+DV5Z_#$KFM9IG^HUY-0ZR<%HM-KEVAB*J$!,ZI(N
MRQLFQ*H<@ 0YRH 8Q  HB(!Z\ B>@<6<<91)DFLMY,YGS6925!=.6H&$9;3I
M--<HB)5B/Z[58YT14HB(@H54#@(B(&\%;;O;>[;+,?T_IX(8'+5L]05:O&Z#
MMLN42+-G**:Z"Q!_J15%4ITU"CZ#V4Y1 ?\ UX!'XXYD1G?[@;*\W,_^7S_6
MC1ZP+OY_G^7ZD8O[WR_(_P OG[_(_GP)>>G+(=*KG&>45W-R%)H=,IS^RK-7
M%C>U6KP=>=S[ABF=%DO-N8ABS6E5F:*JB355^=<[=-0Z:1B%.8! W/P#@7]9
M;ZREV^E9<L,BJ_AM6V:%UB&GW<BA,7&6I4I$O8F2;LT#LI)E"V-HLU425,99
MNO$?=%0 ,1V0OL@R:QHWTCW-V+'&XF.4Y[9%7L*^OCN/2,G!PE4PS*,V=SXI
M$2?V&5M^C-V)E2B8#*,(V0S95X4H^O92R#,3?G^9??XI78A-S=6[^SL_6:5V
M[J=:;2]@Z[S#/8N<9B=H.%\GI5^XQ)5!$HJ$G]OW7HFIO'B?HQD55\Z*S ?A
M]Z/7 ION#%,$^;GPD>1^GCE=K2^.^ZWU!U")P_U,=LF]6V+HK\3?\O[IC6)_
MX/8A+IJ![+]F7S9\BDD8Z2!$DU%"G"6KH7S-R^Y:C*L1QK"J\2I8ID^;Y'6$
MP3 (#-*36Z1$'%(! BBS"MQL:V76_)A,NLFHL<YCG.H8YS&$&V[VWO4E#P0/
M #P \ / #P \ IWOW'$9T#=XV[/^C^Q,F+'UMI6E*?@/15NR*D2:;21E)$LU
M)0=;(112R+_NIV+N9;/FKES',8MJH @P0. J<8)[J2.H_P"G!FC+X?J.D/J$
MRH$]>PD/J#=:D^8@)C 8XQFJ1QOZF'V4IBD$/B42B4A *'$]/QL^P^)?3LP<
M?0R>A]L3XE6(L0)GZC/?:Z1?@  "0M&W231FJB8?8J)KME?N^Q!03$]% 7B>
M5G\;/L.9OIW\J+__ "=6U"PA\C',6V],=.W BHF^/L%T[3L4P1P4?B _!8JA
M $3"!0$YA,)+TZ+V,S#Z</ S)RD^<<><ZV.204^ZA+WG*:CH4VBK[]_=2F[U
M&6*634]_G[A'A3__ +X'%:S:V<>"S%'RS,<Q:'89KG%#SU@H4I%&5'J%>J;0
MY"?["G;0$='HF*7T'Q*8@@7^P!X(;YX > '@!X > '@!X > '@!X > '@!X
$> ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
